Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy

Journal of Gynecologic Oncology

Volumn 21, Issue 1, 2010, Pages 18-23

  Lee, Dae Woo ^a   Kim, Young Tae ^a   Kim, Jae Hoon ^a   Kim, Sunghoon ^a   Kim, Sang Wun ^a   Nam, Eun Ji ^a   Kim, Jae Wook ^b  

^a Yonsei University   (South Korea)

^b Catholic Kwandong University   (South Korea)

Author keywords

Cervical neoplasms; Chemoradiation therapy; MRI; Tumor volume

Indexed keywords

CISPLATIN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 77953399682     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2010.21.1.18     Document Type: Article

References (28)

1. Hricak H, Yu KK. Radiology in invasive cervical cancer. AJR Am J Roentgenol 1996; 167: 1101-1108
2. National Cancer Institute. NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival. Bethesda: National Cancer Institute; 1999.
3. 3. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 29: 9-16. (Pubitemid 24138859)
4. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992; 70: 648-655
5. 5. Micke O, Bruns F, Schafer U, Fron FJ, Willich N. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-) radiotherapy. Anticancer Res 2005; 25: 1663-1666 (Pubitemid 40896781)
6. 6. Ogino I, Nakayama H, Okamoto N, Kitamura T, Inoue T. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy. Int J Gynecol Cancer 2006; 16: 1094-1100 (Pubitemid 43886732)
7. Scheidler J, Heuck AF. Imaging of cancer of the cervix. Radiol Clin North Am 2002; 40: 577-590
8. 8. Amendola MA, Hricak H, Mitchell DG, Snyder B, Chi DS, Long HJ 3rd, et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J Clin Oncol 2005; 23: 7454-7459 (Pubitemid 46291807)
9. Thoms WW Jr, Eifel PJ, Smith TL Morris M, Delclos L Wharton JT, et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 1992; 23: 491-499
10. Ebner F, Tamussino K, Kressel HY. Magnetic resonance imaging in cervical carcinoma: diagnosis, staging, and follow-up. Magn Reson Q 1994; 10: 22-42.
11. Narayan K, McKenzie A, Fisher R, Susil B, Jobling T, Bernshaw D. Estimation of tumor volume in cervical cancer by magnetic resonance imaging. AmJ Clin Oncol 2003; 26: e163-8.
12. 12. Oellinger JJ, Blohmer JU, Michniewicz K, Siewert C, Wust P, Gutberlet M, et al. Pre-operative staging of cervical cancer comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol 2000; 122: 82-91. (Pubitemid 30114997)
13. Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Cancer 1992; 69: 1750-1758
14. 14. Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr 2004; 28: 620-627 (Pubitemid 39195536)
15. 15. Yu KK, Hricak H, Subak IX, Zaloudek CJ, Powell CB. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR Am J Roentgenol 1998; 171: 707-711 (Pubitemid 28406135)
16. Kawagoe T, Kashimura M, Matsuura Y, Sugihara K, Toki N, Aoki T. Clinical significance of tumor size in stage IB and II carcinoma of the uterine cervix. Int J Gynecol Cancer 1999; 9: 421-426
17. Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999; 85: 1547-1554
18. 18. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002; 81: 1144-1151 (Pubitemid 35454363)
19. 19. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 1990; 39: 175-180 (Pubitemid 20372408)
20. 20. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990; 65: 1923-1927 (Pubitemid 20147629)
21. 21. Kamura T, Tsukamoto N, Tsuruchi N, Kaku T, Saito T, To N, et al. Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection: an analysis with mathematical statistics. Int J Gynecol Cancer 1993; 3: 219-225 (Pubitemid 23361860)
22. 22. Suprasert P Srisomboon J, Kasamatsu T. Radical hysterectomy for stage IIB cervical cancer a review. Int J Gynecol Cancer 2005; 15: 995-1001. (Pubitemid 43110147)
23. 23. Rose PG, Adler LR Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999; 17: 41-45 (Pubitemid 29022376)
24. 24. Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer potential impact on treatment. Int J Gynecol Cancer 2001; 11: 263-271 (Pubitemid 32751393)
25. 25. Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002; 52: 14-22. (Pubitemid 34041563)
26. 26. Hatano K, Sekiya Y, Araki H, Sakai M, Togawa T, Narita Y, et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1999; 45: 639-644 (Pubitemid 29462644)
27. 27. Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL Miller DS, et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol 2002; 84: 115-119 (Pubitemid 34056476)
28. 28. Molina R, Fuella X, Lejarcegui JA, Pahisa J, Torne A, Rovirosa A, et al. Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumour Biol 2003; 24: 156-164 (Pubitemid 37465053)